GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

International Journal of Clinical Oncology (Record no. 3774)

MARC details
000 -LEADER
fixed length control field 02010nas a22003255i 4500
001 - CONTROL NUMBER
control field 1437-7772
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610082524.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150723s||||||||si uu poo|||||| b|EN |d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1437-7772
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/10147.1437-7772
Source of number or code doi
210 10 - ABBREVIATED TITLE
Abbreviated title Int J Clin Oncol
245 10 - TITLE STATEMENT
Title International Journal of Clinical Oncology
Medium [electronic resource] /
Statement of responsibility, etc. edited by Noriomi Matsumura, Masaki Mandai.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Singapore :
Name of producer, publisher, distributor, manufacturer Springer Nature Singapore :
-- Imprint: Springer.
300 ## - online resource
Other physical details online resource.
520 ## - SUMMARY, ETC.
Summary, etc. The International Journal of Clinical Oncology (IJCO) welcomes original and review papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Priority is given to high-quality clinical articles, including prospective randomized studies, rather than retrospective studies. Basic and translational studies will only be accepted if they have obvious clinical significance. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that their content has not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer—Treatment.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Therapy.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Biology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Matsumura, Noriomi.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mandai, Masaki.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed version:
International Standard Serial Number 1341-9625
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/10147.1437-7772">https://doi.org/10.1007/10147.1437-7772</a>
Public note Hybrid

No items available.